Aktiia 24/7 Blood Pressure Monitor
Cuffless, optical blood pressure monitoring wearable for continuous tracking
Device · EmbeddedCompany source
Company profile
About Aktiia
Aktiia is a medical technology company specializing in optical blood pressure monitoring solutions integrated into wearable devices. The company has developed a clinically validated, cuffless blood pressure monitoring system that enables continuous tracking throughout the day and night. Aktiia's technology is designed to provide accurate blood pressure measurements without the need for traditional inflatable cuffs, making it suitable for remote patient monitoring and chronic disease management, particularly for hypertension. The company's approach combines optical sensors with proprietary algorithms to deliver medical-grade blood pressure data that can be accessed by both patients and healthcare providers. Aktiia serves healthcare systems, medical device manufacturers, and consumers seeking continuous cardiovascular monitoring solutions. The company's technology aims to improve hypertension management by providing more comprehensive blood pressure data than traditional spot measurements, enabling better treatment decisions and patient outcomes.
Company description Aktiia official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Aktiia?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiovascular disease
- hypertension
Who it serves
- Consumers
- Health Systems
- Medical Device Manufacturers
- Providers
Deployment & integration
Embedded deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension Management.American journal of hypertension · Apr 15, 2025
Evaluation of Aktiia cuffless blood pressure monitor across 24-h, daytime, and night-time measurements versus ambulatory monitoring: a prospective, single-centre observational study.Journal of hypertension · Apr 1, 2025
The quest for blood pressure markers in photoplethysmography and its applications in digital health.Frontiers in digital health · Jan 1, 2025
Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring.Frontiers in medicine · Jan 1, 2024
Performance of the Aktiia optical blood pressure measurement device in the elderly: a comparison with double blinded auscultation in different body positions.Blood pressure · Dec 1, 2023
The future of blood pressure monitoring: what's next?Hypertension research : official journal of the Japanese Society of Hypertension · Sep 1, 2023
Clinical validation
Clinical-trial records
Wearable Evaluation of Ambulatory Readings for Blood PressureNCT06610448 · Mentioned · RECRUITING
Arlington Aging StudyNCT06857877 · Mentioned · RECRUITING
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring DeviceNCT07507903 · Sponsor · NOT YET RECRUITING
WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure ControlNCT07523269 · Sponsor · RECRUITING
Aktiia OPBM Single-center Prospective Observational Study Against Double AuscultationNCT04027777 · Sponsor · RECRUITING
OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications IntakeNCT05780710 · Sponsor · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
continuous blood pressure monitoring
24/7 tracking without cuff inflation
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Aktiia
Recent articles published on Aktiia's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.